Dr. Christopher Kolasa, MD

Dr. Kolasa practices at Nephrology & Hypertension Medical Assoc. in Savannah, Georgia.

Dr. Kolasa's NPI, 1073680062, was assigned on November 29, 2006. Dr. Kolasa graduated from Medical University of Lodz in 1983. Dr. Kolasa's Georgia license number on file is 102416.

Dr. Kolasa's primary practice is Nephrology & Hypertension Medical Assoc., at 1115 Lexington Ave, Savannah, GA 31404 in Chatham County. The practice phone is (912) 588-1919.

Dr. Kolasa's primary practice is Nephrology & Hypertension Medical Assoc. in Savannah, Georgia. Dr. Kolasa is also affiliated with Southeast Georgia Health System-Brunswick Campus. The medical group on file is Nephrology & Hypertension Medical Associates. Dmand AI also links Dr. Kolasa to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kolasa practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kolasa's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kolasa is board certified in internal medicine by the National Board of Physicians and Surgeons. Dmand AI has Dr. Kolasa's licenses on file in 3 states: Georgia, New Jersey and New York.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, gout and kidney failure among the conditions Dr. Kolasa treats.

CMS data shows 759 Medicare services from Dr. Kolasa across 6 procedure codes in 2024, for 199 Medicare patients. Medicare paid $98,668 for them.

CMS counts 199 Medicare patients who saw Dr. Kolasa in 2024. The largest group is 65 to 74, with 92 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kolasa's median patient age at 70, with 55% women.

In 2024, Dr. Kolasa wrote 1,977 Medicare Part D claims for 214 patients. 91% of them were for generic drugs. CMS names the drug for 1,574 of them, across 45 drugs with 11 or more claims each, at $113,451 in total drug cost. In 2023, CMS named 1,667 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Kolasa for performance year 2024, reported individually. Dr. Kolasa accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 29 general payments to Dr. Kolasa from 17 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 87% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $187.

Dmand AI lists 1 award for Dr. Kolasa, most recently CMS Stage 1 EHR in 2013.

Dr. Kolasa graduated from Medical University of Lodz in 1983. Dr. Kolasa is a member of ASN.

Dr. Kolasa is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.